Fling Pharmaceuticals Private Limited - Company Profile

It is a pharma private limited company based in Thrissur, Kerala, India, established in 2005.
2005 Thrissur, Kerala, India Active
Last Updated:
Access Report
About Fling Pharmaceuticals Private Limited

Fling Pharmaceuticals Private Limited, a active private limited company, was established on 18 November 2005 in Thrissur, Kerala, India. Engaging in drug formulation & development within the manufacturing sector, it holds CIN: U24232KL2005PTC018835. Registered under ROC Roc Ernakulam. it is unlisted. It has an authorized capital of ₹1.00 Cr and a paid-up capital of ₹9.98 M.

It upholds a compliant status. Employing 40 professional, Its leadership includes Madhu Karuvanchery Vijayan Nair (Managing Director), Biju Kapplingattu Krishnan Namboodiri (Whole-Time Director), David Joseph Palayoor (Whole-Time Director). Past directors included Madhu Karuvanchery Vijayan Nair, Bhagya Lakshmi Ravindranathan, Biju Kapplingattu Krishnan Namboodiri. It holds ₹7.75 Cr open charges and ₹1.38 Cr settled loans. Its latest AGM occurred on 30 September 2024, with the balance sheet filed on 31 March 2024. It is based at No. B1, 31/441/5, First Floor, Navamy Regency Sitaram Mill Road, Punkunnam P.O., Thrissur, Kerala, 680002.

Company Details
  • Email
    **********
  • Telephone

    +91-XXXXXXXXXX

  • Website
    **********
  • Social Media
    **********
  • Apps
    **********

Company Details

  • CIN/LLPIN

    U24232KL2005PTC018835

  • Registration Number

    018835

  • Incorporation Date

    18 November 2005

  • Authorized Capital

    ₹1.00 Cr

  • Paid-Up Capital

    ₹9.98 M

  • ROC Code

    Roc Ernakulam

  • Listing Status

    Unlisted

  • Company Status

    Active

Key Metrics
  • Authorised Capital ₹ 1.00 Cr
  • Paid Up Capital ₹ 9.98 M
  • Company Age 20 Year, 3 Months
  • Last Filing with ROC 31 Mar 2024
  • Open Charges ₹ 7.75 Cr
  • Satisfied Charges ₹ 1.38 Cr
  • Revenue Growth **** 29.19%
  • Profit Growth **** 71.65%
  • Ebitda **** 43.83%
  • Net Worth 46.23%
  • Total Assets **** 11.91%
Company report

Fling Pharmaceuticals Private Limited

Company Report FY 2025-2026

Comprehensive Company Insights

Explore comprehensive insights into Fling Pharmaceuticals Private Limited — covering financial performance, compliance records, Competitor, shareholding patterns, directors, key metrics, and litigation history. Unlock to see detailed insights and stay informed.

Access Report
Who are the key members and board of directors at Fling Pharmaceuticals Private Limited?
Current Directors
Name Designation Appointment Date Status
Madhu Karuvanchery Vijayan Nair Managing Director 01 Apr 2024 Current
Biju Kapplingattu Krishnan Namboodiri Whole-Time Director 11 Mar 2009 Current
David Joseph Palayoor Whole-Time Director 12 May 2010 Current
Past Directors
Name Designation Cessation Status
Pramod Abcsdd Director 05 May 2023 Past
Pramod Abcsdd Director 05 Mar 2019 Past
Pramod Abcsdd Director 03 Apr 2009 Past
Pramod Abcsdd Director 11 Mar 2009 Past
Pramod Abcsdd Managing Director 01 Apr 2024 Past

Discover detailed profiles of directors and KMP - Unlock leadership insights today!

Financial Performance of Fling Pharmaceuticals.

Fling Pharmaceuticals Private Limited, for the financial year ended 2023, experienced significant growth in revenue, with a 29.19% increase. The company also saw a substantial improvement in profitability, with a 71.65% increase in profit. The company's net worth Soared by an impressive increase of 46.23%.

Fling Pharmaceuticals revenue growth over time
Fling Pharmaceuticals profit and loss trends over time
Date Amount Transaction Name Valuation Lead Investors Investors
Jul, 2021 Amount Post-IPO - Grab Valuation

investors
Emtek
Feb, 2021 Amount Post-IPO - Grab Valuation

investors
Signite Partners
Jan, 2021 Amount Post-IPO - Grab Valuation

investors
Hana Financial Group , GGV Capital
Feb, 2021 Amount Post-IPO - Grab Valuation

investors
Signite Partners
  • Key Matrics
  • Balance Sheet
  • Profit and Loss
  • Cash Flow
  • Ratios
Metrics
(FY 2023) YOY Growth
(FY 2022) (FY 2021) (FY 2020) (FY 2019)
Total Revenue
********
 29.19%
*******
*******
*******
*******
Revenue from Operations
*******
 29.05%
*******
*******
*******
*******
Total Assets
*******
 11.91%
*******
*******
*******
*******
Profit or Loss
*******
 71.65%
*******
*******
*******
*******
Net Worth
*******
 46.23%
*******
*******
*******
*******
EBITDA
*******
 43.83%
*******
*******
*******
*******

Discover detailed financial data and - Unlock financial today!

What is the Ownership and Shareholding Structure of Fling Pharmaceuticals?

In 2023, Fling Pharmaceuticals had a promoter holding of 23.34% and a public holding of 76.66%. The company had 2 Subsidiaries and 2 Associate Companies. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.

Shareholding Pattern (FY 2024)
shareholding
  • Promoters: 92.83%
  • Public: 4.10%
  • Others: 3.07%
Shareholding Pattern over the Year
FY (2024) FY (2023) FY (2022) FY (2021) FY (2020)
Promoters 92.83 94.62 94.55 94.55 94.55
Public 4.10 3.89 3.95 3.96 3.98
Others 3.07 1.49 1.50 1.49 1.47

Reveal ownership structures and financial performance - Get instant access now!

Charges (Loans)
Open Charges

₹77,543,080.00

Satisfied Charges

₹13,800,000.00

Charges Breakdown by Lending Institutions
  • Dhanlaxmi Bank Limited : 6.70 Cr
  • Others : 1.05 Cr
Latest Charge Details
Date Lender Amount Status
04 Oct 2025 Dhanlaxmi Bank Limited ₹3.30 Cr Open
08 Jan 2025 Dhanlaxmi Bank Limited ₹3.40 M Open
19 Aug 2024 Others ₹1.05 Cr Open
03 Aug 2020 Dhanlaxmi Bank Limited ₹2.73 M Open
06 Oct 2018 Dhanlaxmi Bank Limited ₹3.25 M Open

Explore comprehensive loan charge details -

How Many Employees Work at Fling Pharmaceuticals?

Fling Pharmaceuticals has a workforce of 40 employees as of Mar 27, 2024. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.

Employee Date Number of Employees
2020 78,000
2021 80,500
2022 83,200
2023 86,000
2024 89,500
2025 92,000
Deals i
Graph showing company valuation over time

Gain comprehensive insights into the Deals and Valuation data of Fling Pharmaceuticals, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Fling Pharmaceuticals's trajectory.

Rating
Graph displaying rating trends over time

Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.

Alerts
Alert Indicator

Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.

Explore deal ratings and alerts - Get instant access now!

Latest Updates, News, and FAQs on Fling Pharmaceuticals
Recent Activity within the Organization
  • Charges

    Progress on A charge with Dhanlaxmi Bank Limited amounted to Rs. 3.30 Cr with Charge ID 101181785 was registered on 04 Oct 2025. was documented.

  • Charges

    A charge with Dhanlaxmi Bank Limited of Rs. 0.97 Cr registered on 17 Apr 2018 with Charge ID 100176290 was modified on 19 Feb 2025. was recorded as a recent event.

  • Charges

    The activity A charge registered on 22 Mar 2017 via Charge ID 100092649 with Dhanlaxmi Bank Limited was fully satisfied on 19 Feb 2025. was completed.

  • Charges

    A charge registered on 21 Jun 2016 via Charge ID 100039504 with Dhanlaxmi Bank Limited was fully satisfied on 19 Feb 2025. was recorded as a recent event.

  • Charges

    A charge with Dhanlaxmi Bank Limited amounted to Rs. 0.34 Cr with Charge ID 101040710 was registered on 08 Jan 2025. was recorded as a recent event.

  • Charges

    The activity A charge registered on 19 Mar 2013 via Charge ID 10510561 with Dhanlaxmi Bank Limited was fully satisfied on 05 Nov 2024. was completed.

Explore recent activity and updates - View Recent Activity

Frequently Asked Questions
What is the CIN of Fling Pharmaceuticals Private Limited?

The CIN of Fling Pharmaceuticals Private Limited is U24232KL2005PTC018835.

Where is Fling Pharmaceuticals Private Limited headquartered?

Fling Pharmaceuticals Private Limited is headquartered at No. B1, 31/441/5, First Floor, Navamy Regency Sitaram Mill Road, Punkunnam P.O., Thrissur, Kerala, 680002.

When was Fling Pharmaceuticals Private Limited incorporated?

Fling Pharmaceuticals Private Limited was incorporated on 18 November 2005.

Who are the current directors of Fling Pharmaceuticals Private Limited?

The current directors of Fling Pharmaceuticals Private Limited are

What is the primary industry of Fling Pharmaceuticals Private Limited?

The primary industry of Fling Pharmaceuticals Private Limited is Manufacturing.

Is Fling Pharmaceuticals Private Limited a listed company?

Fling Pharmaceuticals Private Limited is unlisted.

What is the capital structure of Fling Pharmaceuticals Private Limited?

The authorized capital of Fling Pharmaceuticals Private Limited is ₹1.00 Cr, and the paid-up capital is ₹9.98 M.

What is the compliance status of Fling Pharmaceuticals Private Limited?

The compliance status of Fling Pharmaceuticals Private Limited is Compliant.

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available